The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,299
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Sohal, D. S., Nghiem, M., Crackower, M. A., Witt, S. A., Kimball, T. R., Tymitz, K. M., Penninger, J. M., & Molkentin, J. D. (2001) · Circulation Research · doi:10.1161/hh1301.092687 · Cited by 695
Self-citationKelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A., & Semenza, G. L. (2003) · Circulation Research · doi:10.1161/01.res.0000102937.50486.1b · Cited by 611
Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J.-I., et al. (2005) · Nature Medicine · doi:10.1038/nm1199 · Cited by 564
Self-citation
Cited by
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Semenza, G. L. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104720 · Cited by 1,159
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
Physiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
Self-citationMolecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Force, T., Krause, D. S., & Van Etten, R. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2106 · Cited by 801
The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension
Vonk Noordegraaf, A., Westerhof, B. E., & Westerhof, N. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.047 · Cited by 780
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
The Right Ventricle Under Pressure
Bogaard, H. J., Abe, K., Vonk Noordegraaf, A., & Voelkel, N. F. (2009) · Chest · doi:10.1378/chest.08-0492 · Cited by 679
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
Hypoxia-Inducible Factor 1 and Cardiovascular Disease
Semenza, G. L. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170322 · Cited by 608
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Self-citationmiR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1
Wang, J.-X., Jiao, J.-Q., Li, Q., Long, B., Wang, K., Liu, J.-P., Li, Y.-R., & Li, P.-F. (2011) · Nature Medicine · doi:10.1038/nm.2282 · Cited by 582
Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure
Bogaard, H. J., Natarajan, R., Henderson, S. C., Long, C. S., Kraskauskas, D., Smithson, L., Ockaili, R., McCord, J. M., & Voelkel, N. F. (2009) · Circulation · doi:10.1161/circulationaha.109.883843 · Cited by 513
Redox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 482
Oka, T., Akazawa, H., Naito, A. T., & Komuro, I. (2014) · Circulation Research · doi:10.1161/circresaha.114.300507 · Cited by 460
Self-citationZhang, M., Brewer, A. C., Schröder, K., Santos, C. X. C., Grieve, D. J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009700107 · Cited by 445
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Yamakuchi, M., Lotterman, C. D., Bao, C., Hruban, R. H., Karim, B., Mendell, J. T., Huso, D., & Lowenstein, C. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911082107 · Cited by 430
Schirone, L., Forte, M., Palmerio, S., Yee, D., Nocella, C., Angelini, F., Pagano, F., Schiavon, S., Bordin, A., Carrizzo, A., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3920195 · Cited by 425
Morimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., Komeda, M., Fujita, M., Shimatsu, A., Kita, T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33160 · Cited by 423
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406
“(Figure 4D) typically seen after 4 weeks of TAC (Sano et al., 2007; Song et al., 2010).”
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Krishnan, J., Suter, M., Windak, R., Krebs, T., Felley, A., Montessuit, C., Tokarska-Schlattner, M., Aasum, E., Bogdanova, A., Perriard, E., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.005 · Cited by 404
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload
Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40295 · Cited by 389
Self-citationHypoxia signaling in human diseases and therapeutic targets
Lee, J. W., Ko, J., Ju, C., & Eltzschig, H. K. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0235-1 · Cited by 384
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Chen, M. H., Kerkelä, R., & Force, T. (2008) · Circulation · doi:10.1161/circulationaha.108.776831 · Cited by 379
Matsumoto, S., Sakata, Y., Suna, S., Nakatani, D., Usami, M., Hara, M., Kitamura, T., Hamasaki, T., Nanto, S., Kawahara, Y., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301209 · Cited by 374
Self-citationForce, T., & Kolaja, K. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3252 · Cited by 363
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
T-cadherin is critical for adiponectin-mediated cardioprotection in mice
Denzel, M. S., Scimia, M.-C., Zumstein, P. M., Walsh, K., Ruiz-Lozano, P., & Ranscht, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43464 · Cited by 347
Koitabashi, N., Danner, T., Zaiman, A. L., Pinto, Y. M., Rowell, J., Mankowski, J., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44824 · Cited by 334
Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes
Naito, A. T., Sumida, T., Nomura, S., Liu, M.-L., Higo, T., Nakagawa, A., Okada, K., Sakai, T., Hashimoto, A., Hara, Y., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.047 · Cited by 320
Self-citationPathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W.-W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 318
Redox signaling in cardiac myocytes
Santos, C. X. C., Anilkumar, N., Zhang, M., Brewer, A. C., & Shah, A. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.003 · Cited by 317
Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure
Kato, T., Niizuma, S., Inuzuka, Y., Kawashima, T., Okuda, J., Tamaki, Y., Iwanaga, Y., Narazaki, M., Matsuda, T., Soga, T., et al. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.888479 · Cited by 308
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Dorn, G. W. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn243 · Cited by 305
Cell Communications in the Heart
Tirziu, D., Giordano, F. J., & Simons, M. (2010) · Circulation · doi:10.1161/circulationaha.108.847731 · Cited by 303
Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis
Revelo, X. S., Parthiban, P., Chen, C., Barrow, F., Fredrickson, G., Wang, H., Yücel, D., Herman, A., & van Berlo, J. H. (2021) · Circulation Research · doi:10.1161/circresaha.121.319737 · Cited by 298
Molecular targets and regulators of cardiac hypertrophy
Rohini, A., Agrawal, N., Koyani, C. N., & Singh, R. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.012 · Cited by 295
Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration
Nishida, M., Sawa, T., Kitajima, N., Ono, K., Inoue, H., Ihara, H., Motohashi, H., Yamamoto, M., Suematsu, M., Kurose, H., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1018 · Cited by 293
DNA damage response and metabolic disease
Shimizu, I., Yoshida, Y., Suda, M., & Minamino, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.008 · Cited by 286
Self-citationShah, A. M., & Mann, D. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60894-5 · Cited by 284
Nomura, S., Satoh, M., Fujita, T., Higo, T., Sumida, T., Ko, T., Yamaguchi, T., Tobita, T., Naito, A. T., Ito, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06639-7 · Cited by 269
Self-citationReciprocal influence of the p53 and the hypoxic pathways
Sermeus, A., & Michiels, C. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.48 · Cited by 265
Chronic Inflammation Links Cardiovascular, Metabolic and Renal Diseases
Manabe, I. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-1184 · Cited by 263
The role of the right ventricle in pulmonary arterial hypertension
Vonk Noordegraaf, A., & Galiè, N. (2011) · European Respiratory Review · doi:10.1183/09059180.00006511 · Cited by 258
Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies
Predmore, J. M., Wang, P., Davis, F., Bartolone, S., Westfall, M. V., Dyke, D. B., Pagani, F., Powell, S. R., & Day, S. M. (2010) · Circulation · doi:10.1161/circulationaha.109.904557 · Cited by 254
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Li, J., Ichikawa, T., Villacorta, L., Janicki, J. S., Brower, G. L., Yamamoto, M., & Cui, T. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.189480 · Cited by 253
Werner, C., Hanhoun, M., Widmann, T., Kazakov, A., Semenov, A., Pöss, J., Bauersachs, J., Thum, T., Pfreundschuh, M., Müller, P., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.034 · Cited by 239
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
Gevaert, A. B., Shakeri, H., Leloup, A. J., Van Hove, C. E., De Meyer, G. R. Y., Vrints, C. J., Lemmens, K., & Van Craenenbroeck, E. M. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003806 · Cited by 211
Vascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196
Self-citationAngiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Lee, S.-J., Lee, C.-K., Kang, S., Park, I., Kim, Y. H., Kim, S. K., Hong, S. P., Bae, H., He, Y., Kubota, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99659 · Cited by 164
Ikeda, M., Ide, T., Fujino, T., Arai, S., Saku, K., Kakino, T., Tyynismaa, H., Yamasaki, T., Yamada, K.-I., Kang, D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119687 · Cited by 152
Deletion of the von Hippel–Lindau gene in pancreatic β cells impairs glucose homeostasis in mice
Cantley, J., Selman, C., Shukla, D., Abramov, A. Y., Forstreuter, F., Esteban, M. A., Claret, M., Lingard, S. J., Clements, M., Harten, S. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci26934 · Cited by 127
Cell-cell interaction in the heart via Wnt/ -catenin pathway after cardiac injury
Deb, A. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu054 · Cited by 102
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Loffredo, G., Rinaldi, L., Catalini, C., Gjeloshi, K., Albanese, G., Di Martino, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092274 · Cited by 98
“The investigators administered empagliflozin to mice suffering from LV pressure overload generated by transverse aortic constriction, a condition associated with the heart reduction of vascular endothelial growth factor-A, capillary rarefaction, and tissue hypoxia, and the progression of systolic dysfunction [294,295].”
Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., Zhang, J., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211796 · Cited by 72
Self-citationKorf-Klingebiel, M., Reboll, M. R., Polten, F., Weber, N., Jäckle, F., Wu, X., Kallikourdis, M., Kunderfranco, P., Condorelli, G., Giannitsis, E., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.053365 · Cited by 71
Hemoglobin S-nitrosylation plays an essential role in cardioprotection
Zhang, R., Hess, D. T., Reynolds, J. D., & Stamler, J. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90425 · Cited by 62
“Compensatory cardiac hypertrophy in response to increased workload is normally accompanied by angiogenesis to maintain oxygenation of hypertrophied cardiomyocytes, and inhibition of angiogenesis leads to heart failure (13).”
BackgroundTanaka, T., Yamaguchi, J., Shoji, K., & Nangaku, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374587 · Cited by 50
“An insufficient angiogenic response by HIF-1 has been suggested to serve as a critical switch toward decompensated heart failure in a mouse model of cardiac hypertrophy (transverse aortic constriction) (21).”
BackgroundCrosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update
Poyton, R., & Hendrickson, M. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58280 · Cited by 45
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy
Huang, Z., Mou, Y., Xu, X., Zhao, D., Lai, Y., Xu, Y., Chen, C., Li, P., Peng, S., Tian, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00971 · Cited by 40
Vidal, J.-S., Dufouil, C., Ducros, V., & Tzourio, C. (2008) · Neuroepidemiology · doi:10.1159/000126914 · Cited by 32
Gupta, S. C., Varian, K. D., Bal, N. C., Abraham, J. L., Periasamy, M., & Janssen, P. M. L. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00026.2009 · Cited by 18
Translation of Cellular Senescence to Novel Therapeutics: Insights From Alternative Tools and Models
Inci, N., Kamali, D., Akyildiz, E. O., Tahir Turanli, E., & Bozaykut, P. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.828058 · Cited by 13
Tada, Y., Ogawa, M., Watanabe, R., Zempo, H., Takamura, C., Suzuki, J.-I., Dan, T., Miyata, T., Isobe, M., & Komuro, I. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.855196 · Cited by 9
Self-citation
Metadata
- Authors
- Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., Shimizu, I., Asahara, T., Hamada, H., Tomita, S., Molkentin, J. D., Zou, Y., & Komuro, I.
- Venue
- Nature
- Published
- 2007-03
- Volume
- 446
- Issue
- 7134
- Pages
- 444-448
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2018183883
- Cited by
- 905
- References
- 25
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.